OPHTAL
19MG/ML+0,1MG/ML OPH AQA 4X25ML
SÚKL code | 0201452 |
---|---|
Name of the product | OPHTAL |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | OPHTAL |
Supplement | 19MG/ML+0,1MG/ML OPH AQA 4X25ML |
Strenght | 19MG/ML+0,1MG/ML |
Pharmaceutical form | Eye lotion |
Package | 4X25ML |
Route | Ocular use |
Language of the pack | Czech |
Wrap type | Dropper container |
Legal status | OTC medicinal products |
Active substance |
BORIC ACID (ACIDUM BORICUM) BENZODODECINIUM BROMIDE SOLUTION 10 PER CENT (BENZODODECINII BROMIDI SOLUTIO 10%) |
ATC group | S01AX |
ATC group name | JINÁ ANTIINFEKTIVA |
Marketing authorisation information
Registration Number | 64/ 525/69-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 04. 2020 |
MA Holder | TEVA Czech Industries s.r.o., Opava-Komárov |
MA Holder country | ČESKÁ REPUBLIKA |
Actual MA holder | Teva B.V., Haarlem |
Actual MA holder country | NIZOZEMSKO |